3Buchwald AB, Hammerschmidt S, Stevens, et al. Inhibition of neointimal proliteration after coronary angioplasty by low molecular weight heparin (clivarine) and polyethycolhirudin [J].J Cardiovasc Pharmacol, 1996, 28 (24): 481-487. 被引量：1
4Bara L, Mardiguian J, Samam M. In vitro effect on heptest of low molecular weight heparin fractions and preparations with various anti- Ⅱ a and anti- Ⅱ activities [J]. Thromb Res, 1990, 57: 585. 被引量：1
5Ejiri M, Miawa K, et al. Effects of heparil treatment or collateral development and regional myocardial function in acute myocardial infarction [J]. Am Heart J, 1990, 119 (): 248. 被引量：1
6Gufinkel EP, Manos EJ, Mefail RI. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent isehemia [J]. J Am Coll Cardiol, 1995, 26: 313. 被引量：1
7Engelberg H, Heparin. Heparin fractions and the aterosclerotic process [J]. Semin Thromb Hemost, 1985, 11: 48-55. 被引量：1
9Choay J, Petitou M, Lormeau JC, et al. Structure activity relationship in heparin: A synthetic pentasaccarde with high affinity for antithrombin Ⅲ, and eliciting high antifactor Xa activity [J]. Biochem Biophys Res Commun, 1983, 116: 492. 被引量：1
10Hubertc, Honot A, Corvol P, et al. Structure of the angiotensin I coverting en zyme gene[J]. Biol Chen, 1991,266：15377-15381. 被引量：1
